Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$376K Buy
1,068
+27
+3% +$9.63K 0.02% 95
2025
Q4
$341K Buy
+1,041
New +$330K 0.02% 105
2025
Q2
$292K Buy
1,046
+14
+1% +$3.97K 0.02% 103
2025
Q1
$322K Sell
1,032
-4
-0.4% -$1.18K 0.02% 91
2024
Q4
$270K Sell
1,036
-1,015
-49% -$301K 0.02% 98
2024
Q3
$657K Buy
2,051
+24
+1% +$7.85K 0.05% 50
2024
Q2
$633K Sell
2,027
-102
-5% -$30K 0.05% 45
2024
Q1
$605K Buy
2,129
+17
+0.8% +$4.97K 0.05% 54
2023
Q4
$608K Buy
2,112
+161
+8% +$43.9K 0.05% 53
2023
Q3
$524K Buy
1,951
+281
+17% +$70.1K 0.04% 54
2023
Q2
$371K Buy
1,670
+38
+2% +$8.82K 0.03% 67
2023
Q1
$395K Sell
1,632
-64
-4% -$15.7K 0.03% 64
2022
Q4
$445K Buy
1,696
+335
+25% +$89.8K 0.03% 63
2022
Q3
$307K Buy
1,361
+110
+9% +$26.7K 0.02% 64
2022
Q2
$304K Buy
1,251
+92
+8% +$22.5K 0.02% 75
2022
Q1
$280K Buy
+1,159
New +$266K 0.02% 89
2019
Q3
Sell
-1,180
Closed -$217K 33
2019
Q2
$217K Buy
+1,180
New +$211K 0.08% 49

Other funds holding AMGN

Hamilton Capital's AMGN Position: Q1 2026 in Review

Hamilton Capital increased its Amgen (AMGN) stake by 2.6% in Q1 2026, buying an estimated $9.63K and bringing the position to 1,068 shares worth $376K. The position accounts for 0.02% of the portfolio, ranked #95.

Hamilton Capital first reported a position in AMGN in Q2 2019 and has held it in 17 quarters since. The position peaked at $657K in Q3 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Hamilton Capital held 1,068 shares of Amgen worth $376K as of Q1 2026.
  • Hamilton Capital bought 27 Amgen shares in Q1 2026, an estimated $9.63K.
  • Amgen made up 0.02% of Hamilton Capital's portfolio in Q1 2026, its #95 holding.
  • Hamilton Capital first reported a position in Amgen in Q2 2019 and has held it in 17 quarters since.
  • Hamilton Capital's Amgen position peaked at $657K in Q3 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Hamilton Capital's 13F filing for Q1 2026, filed 15 May 2026.